Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DCG-IV is an effective agonist of class II mGluR. DCG-IV has anticonvulsant and neuroprotective effects. The EC50 of mGlu2R and mGlu3R are 0.35 and 0.09 μM, respectively. DCG-IV is also a competitive antagonist of Group I (IC50: mGlu1 / 5R = 389/630 μM) and III receptor (IC50: mGlu4 / 6/7 / 8R = 22.5 / 39.6 / 40.1 / 32 μM).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 5,210 | 35日内发货 | ||
10 mg | ¥ 11,100 | 35日内发货 | ||
50 mg | ¥ 44,900 | 35日内发货 |
产品描述 | DCG-IV is an effective agonist of class II mGluR. DCG-IV has anticonvulsant and neuroprotective effects. The EC50 of mGlu2R and mGlu3R are 0.35 and 0.09 μM, respectively. DCG-IV is also a competitive antagonist of Group I (IC50: mGlu1 / 5R = 389/630 μM) and III receptor (IC50: mGlu4 / 6/7 / 8R = 22.5 / 39.6 / 40.1 / 32 μM). |
靶点活性 | mGluR5:630 μM (IC50), mGluR1R:389 μM (IC50), mGluR2R:0.35 μM (EC50), mGluR6:39.6 μM (IC50), mGluR3R:0.09 μM (EC50), mGluR4R:22.5 μM (IC50), mGluR7:40.1 μM (IC50), mGluR8:32 μM (IC50) |
体外活性 | DCG-IV is also a NMDA receptor agonist in rat cerebral cortex. |
体内活性 | DCG-IV (1-10 mg / kg; i.p.) inhibits hyperactivity caused by phencyclidine (PCP). |
分子量 | 203.15 |
分子式 | C7H9NO6 |
CAS No. | 147782-19-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
DCG-IV 147782-19-2 Others DCG IV DCGIV Inhibitor inhibitor inhibit